Fat deposition decreases diffusion parameters at MRI: A study in phantoms and patients with liver steatosis

European Radiology

Volumn 23, Issue 2, 2013, Pages 461-467

  Leitão, Helena S ^a,b   Doblas, Sabrina ^b   D'Assignies, Gaspard ^b   Garteiser, Philippe ^b   Daire, Jean Luc ^b   Paradis, Valérie ^c   Geraldes, Carlos F G C ^a   Vilgrain, Valérie ^b   Van Beers, Bernard E ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Paris Nord Val de Seine University Hospitals   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Diffusion weighted MRI; Liver; Magnetic resonance imaging; Phantom imaging; Steatosis

Indexed keywords

LIPID EMULSION;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIPID STORAGE; LIVER PERFUSION; MALE; MEASUREMENT; PHANTOM; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84872972813     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2626-8     Document Type: Article

References (36)

1. Roulot D, Costes JL, Buyck JF, et al. (2011) Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 60:977-984
2. Szczepaniak LS, Nurenberg P, Leonard D, et al. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462-E468
3. Stefan N, Kantartzis K, Haring HU (2008) Causes and metabolic consequences of fatty liver. Endocr Rev 29:939-960
4. Wang Y, Ganger DR, Levitsky J, Sternick LA, McCarthy RJ, Chen ZE, et al. (2011) Assessment of chronic hepatitis and fibrosis: comparison of magnetic resonance elastography (MRE) and diffusion-weighted imaging (DWI). Am J Roentgenol 196:553-561
5. Bonekamp S, Torbenson MS, Kamel IR (2011) Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol 45:885-892
6. Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V (2008) Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 28:89-95
7. Lewin M, Poujol-Robert A, Boelle P-Y, et al. (2007) Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658-665
8. Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE (2007) Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 25:122-128
9. Luciani A, Vignaud A, Cavet M, et al. (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 249:891-899
10. Pais R, Pascale A, Fedchuck L, Charlotte F, Poynard T, Ratziu V (2011) Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease. Clin Res Hepatol Gastroenterol 35:23-28
11. Sirlin CB (2009) Non invasive imaging biomarkers for steatosis assessment. Liver Transpl 15:1389-1391
12. d'Assignies G, Ruel M, Khiat A, et al. (2009) Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods. Eur Radiol 19:2033-2040
13. Lee JT, Liau J, Murphy P, Schroeder ME, Sirlin CB, Bydder M (2012) Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging. Magn Reson Imaging 30:572-578
14. Anderson SW, Soto JA, Milch HN, et al. (2011) Effect of diffusion progression on liver apparent diffusion coefficient values in a murine model of NASH at 11.7 Tesla MRI. J Magn Reson Imaging 33:882-888
15. Poyraz AK, Onur MR, Kocakoç E, Ogur E (2012) Diffusion-weighted MRI of fatty liver. J Magn Reson Imaging 35:1108-1111
16. Gimsberg HN, Goldberg IJ (2001) Disorders of the lipoprotein metabolism. In: Braunvald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Disorders of the intermediary metabolism. (Harrison's principals of internal medicine), 15th edn. Mc Graw-Hill, USA, p 2246
17. Crawford JM (2007) Basic mechanisms in hepatopathology. In: Burt AD, Portmann BC, Ferrell LD (eds) MacSween's pathology of the liver, 5th edn. Churchill Livingstone Elsevier, Philadelphia, Philadelphia, p 85
18. Brunt EM, Tiniakos DG (2010) Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 16:5286-5296
19. Le Bihan D, Breton E, Lallemand D, Aubin M-L, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497-505
20. Kim SY, Lee SS, Byun JH, et al. (2010) Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology 255:815-823
21. Ababneh ZQ, Beloeil H, Berde CB, Ababneh AM, Maier SE, Mulkern RV (2009) In vivo lipid diffusion coefficient measurements in rat bone marrow. Magn Reson Imaging 27:859-864
22. Qiao Y, Ronen I, Viereck J, Ruberg FL, Hamilton JA (2007) Identification of atherosclerotic lipid deposits by diffusion-weighted imaging. Arterioscler Thromb Vasc Biol 27:1440-1446
23. Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729-749
24. Wenkel E, Geppert C, Schulz-Wendtland R, et al. (2007) Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. Acad Radiol 14:1077-1083
25. Baron P, Dorrius MD, Kappert P, Oudkerk M, Sijens PE (2010) Diffusion-weighted imaging of normal fibroglandular breast tissue: influence of microperfusion and fat suppression technique on the apparent diffusion coefficient. NMR Biomed 23:399-405
26. O'Reagan DP, Callaghan MF, Wylezinska-Arridge M, Fitzpatrick J, Naoumova RP, Hajnal JV, et al. (2008) Liver fat content and T2*: simultaneous measurements by using breath-hold multiecho MR imaging at 3.0 T - feasibility. Radiology 247:550-557
27. Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna BJ, et al. (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 237:1048-1055
28. Marsman H, Matsushita T, Dierkhising R, Kremers W, Rosen C, Burgart L (2004) Assessment of donor liver steatosis: pathologist or automated software. Hum Pathol 35:430-435
29. Farrell GC, Teoh NC, McCuskey RS (2008) Hepatic microcirculation in fatty liver disease. Anat Rec 291:684-692
30. King MD, van Bruggen N, Busza AL, Houseman J, Williams SR, Gadian DG (1992) Perfusion and diffusion MR imaging. Magn Reson Med 24:288-301
31. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC (2004) Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 40:386-393
32. Yokoo T, Bydder M, Hamilton G, et al. (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251:67-76
33. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE (2003) Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229:409-414
34. Paradis V, Bedossa P (2008) Definition and natural history of metabolic steatosis: histology and cellular aspects. Diabetes Metab 34:638-642
35. Padhani AR, Liu G, Mu-Koh D, et al. (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102-125
36. Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 31:589-600